FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094563417> ?p ?o ?g. }

• W2094563417 endingPage "6291" @default.
• W2094563417 startingPage "6286" @default.
• W2094563417 abstract "Damage to DNA is caused by ionizing radiation, genotoxic chemicals or collapsed replication forks. When DNA is damaged or cells fail to respond, a mutation that is associated with breast or ovarian cancer may occur. Mammalian cells control and stabilize the genome using a cell cycle checkpoint to prevent damage to DNA or to repair damaged DNA. Checkpoint kinase 2 (Chk2) is one of the important kinases, which strongly affects DNA-damage and plays an important role in the response to the breakage of DNA double-strands and related lesions. Therefore, this study concerns Chk2. Its purpose is to find potential inhibitors using the pharmacophore hypotheses (PhModels) and virtual screening techniques. PhModels can identify inhibitors with high biological activities and virtual screening techniques are used to screen the database of the National Cancer Institute (NCI) to retrieve compounds that exhibit all of the pharmacophoric features of potential inhibitors with high interaction energy. Ten PhModels were generated using the HypoGen best algorithm. The established PhModel, Hypo01, was evaluated by performing a cost function analysis of its correlation coefficient (r), root mean square deviation (RMSD), cost difference, and configuration cost, with the values 0.955, 1.28, 192.51, and 16.07, respectively. The result of Fischer's cross-validation test for the Hypo01 model yielded a 95% confidence level, and the correlation coefficient of the testing set (rtest) had a best value of 0.81. The potential inhibitors were then chosen from the NCI database by Hypo01 model screening and molecular docking using the cdocker docking program. Finally, the selected compounds exhibited the identified pharmacophoric features and had a high interaction energy between the ligand and the receptor. Eighty-three potential inhibitors for Chk2 are retrieved for further study." @default.
• W2094563417 created "2016-06-24" @default.
• W2094563417 creator A5012061297 @default.
• W2094563417 creator A5015152594 @default.
• W2094563417 creator A5017297488 @default.
• W2094563417 creator A5043071023 @default.
• W2094563417 creator A5066829937 @default.
• W2094563417 date "2013-12-01" @default.
• W2094563417 modified "2023-10-18" @default.
• W2094563417 title "Design checkpoint kinase 2 inhibitors by pharmacophore modeling and virtual screening techniques" @default.
• W2094563417 cites W1496186685 @default.
• W2094563417 cites W1542066560 @default.
• W2094563417 cites W1545084887 @default.
• W2094563417 cites W1567427264 @default.
• W2094563417 cites W1680854530 @default.
• W2094563417 cites W1969431807 @default.
• W2094563417 cites W1970255771 @default.
• W2094563417 cites W1981748664 @default.
• W2094563417 cites W1989602486 @default.
• W2094563417 cites W1989665806 @default.
• W2094563417 cites W2026470547 @default.
• W2094563417 cites W2032337333 @default.
• W2094563417 cites W2033589276 @default.
• W2094563417 cites W2037373214 @default.
• W2094563417 cites W2043050464 @default.
• W2094563417 cites W2050376635 @default.
• W2094563417 cites W2050537711 @default.
• W2094563417 cites W2050686338 @default.
• W2094563417 cites W2055354487 @default.
• W2094563417 cites W2072742549 @default.
• W2094563417 cites W2085998846 @default.
• W2094563417 cites W2088154247 @default.
• W2094563417 cites W2096541451 @default.
• W2094563417 cites W2100956291 @default.
• W2094563417 cites W2108700206 @default.
• W2094563417 cites W2117355601 @default.
• W2094563417 cites W2117389132 @default.
• W2094563417 cites W2132854955 @default.
• W2094563417 cites W2141599662 @default.
• W2094563417 cites W2144112069 @default.
• W2094563417 cites W2148362722 @default.
• W2094563417 cites W2154141161 @default.
• W2094563417 cites W2155631470 @default.
• W2094563417 cites W2160538256 @default.
• W2094563417 cites W2163952383 @default.
• W2094563417 cites W2164905805 @default.
• W2094563417 cites W2221416409 @default.
• W2094563417 cites W265173753 @default.
• W2094563417 doi "https://doi.org/10.1016/j.bmcl.2013.09.080" @default.
• W2094563417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24144850" @default.
• W2094563417 hasPublicationYear "2013" @default.
• W2094563417 type Work @default.
• W2094563417 sameAs 2094563417 @default.
• W2094563417 citedByCount "2" @default.
• W2094563417 countsByYear W20945634172015 @default.
• W2094563417 countsByYear W20945634172016 @default.
• W2094563417 crossrefType "journal-article" @default.
• W2094563417 hasAuthorship W2094563417A5012061297 @default.
• W2094563417 hasAuthorship W2094563417A5015152594 @default.
• W2094563417 hasAuthorship W2094563417A5017297488 @default.
• W2094563417 hasAuthorship W2094563417A5043071023 @default.
• W2094563417 hasAuthorship W2094563417A5066829937 @default.
• W2094563417 hasConcept C103697762 @default.
• W2094563417 hasConcept C104317684 @default.
• W2094563417 hasConcept C105696609 @default.
• W2094563417 hasConcept C143425029 @default.
• W2094563417 hasConcept C1491633281 @default.
• W2094563417 hasConcept C159110408 @default.
• W2094563417 hasConcept C185592680 @default.
• W2094563417 hasConcept C2775905019 @default.
• W2094563417 hasConcept C29537977 @default.
• W2094563417 hasConcept C41685203 @default.
• W2094563417 hasConcept C50001416 @default.
• W2094563417 hasConcept C552990157 @default.
• W2094563417 hasConcept C55493867 @default.
• W2094563417 hasConcept C56173144 @default.
• W2094563417 hasConcept C70721500 @default.
• W2094563417 hasConcept C71924100 @default.
• W2094563417 hasConcept C86803240 @default.
• W2094563417 hasConceptScore W2094563417C103697762 @default.
• W2094563417 hasConceptScore W2094563417C104317684 @default.
• W2094563417 hasConceptScore W2094563417C105696609 @default.
• W2094563417 hasConceptScore W2094563417C143425029 @default.
• W2094563417 hasConceptScore W2094563417C1491633281 @default.
• W2094563417 hasConceptScore W2094563417C159110408 @default.
• W2094563417 hasConceptScore W2094563417C185592680 @default.
• W2094563417 hasConceptScore W2094563417C2775905019 @default.
• W2094563417 hasConceptScore W2094563417C29537977 @default.
• W2094563417 hasConceptScore W2094563417C41685203 @default.
• W2094563417 hasConceptScore W2094563417C50001416 @default.
• W2094563417 hasConceptScore W2094563417C552990157 @default.
• W2094563417 hasConceptScore W2094563417C55493867 @default.
• W2094563417 hasConceptScore W2094563417C56173144 @default.
• W2094563417 hasConceptScore W2094563417C70721500 @default.
• W2094563417 hasConceptScore W2094563417C71924100 @default.
• W2094563417 hasConceptScore W2094563417C86803240 @default.
• W2094563417 hasFunder F4320321040 @default.
• W2094563417 hasFunder F4320321524 @default.

• next